Diroximel fumarate
- Generic Name
- Diroximel fumarate
- Brand Names
- Vumerity
- Drug Type
- Small Molecule
- Chemical Formula
- C11H13NO6
- CAS Number
- 1577222-14-0
- Unique Ingredient Identifier
- K0N0Z40J3W
- Background
Multiple Sclerosis (MS) is a chronic, debilitating neurological disease that can lead to profound cognitive and physical symptoms, severely affecting quality of life. It is the main cause of neurological disability not caused by trauma in the young adult population of both North America and Europe. Relapsing-remitting forms of MS lead to neurological symptom...
- Indication
Diroximel fumarate is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults; specifically active secondary progressive disease and clinically isolated syndrome, as well as relapsing-remitting MS.
- Associated Conditions
- Clinically Isolated Syndrome (CIS), Relapsing Remitting Multiple Sclerosis (RRMS), Active Secondary Progressive Multiple Sclerosis (SPMS)
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath